Low-level antibacterial resistance: a gateway to clinical resistance
- 1 April 2001
- journal article
- review article
- Published by Elsevier in Drug Resistance Updates
- Vol. 4 (2) , 93-105
- https://doi.org/10.1054/drup.2001.0196
Abstract
No abstract availableKeywords
This publication has 74 references indexed in Scilit:
- Molecular Investigation of the Postantibiotic Effects of Clarithromycin and Erythromycin on Staphylococcus aureus CellsAntimicrobial Agents and Chemotherapy, 1999
- Emergence of vancomycin tolerance in Streptococcus pneumoniaeNature, 1999
- Genetic Methods for Assessing Antimicrobial ResistanceAntimicrobial Agents and Chemotherapy, 1999
- The acrAB homolog of Haemophilus influenzae codes for a functional multidrug efflux pumpJournal of Bacteriology, 1997
- The response of Enterobacteriaceae to beta-lactam antibiotics--'round forms, filaments and the root of all evil'.Journal of Antimicrobial Chemotherapy, 1997
- AcrAB efflux pump plays a major role in the antibiotic resistance phenotype of Escherichia coli multiple-antibiotic-resistance (Mar) mutantsJournal of Bacteriology, 1996
- Overproduction of 3'-aminoglycoside phosphotransferase type I confers resistance to tobramycin in Escherichia coliAntimicrobial Agents and Chemotherapy, 1993
- Factors determining resistance to β-lactam combined with β-lactamase inhibitors in Escherichia coliJournal of Antimicrobial Chemotherapy, 1991
- Penicillin Resistance and Defective Lysis in Clinical Isolates of Pneumococci: Evidence for Two Kinds of Antibiotic Pressure Operating in the Clinical EnvironmentThe Journal of Infectious Diseases, 1988
- Aminoglycoside phosphotransferase-II-mediated amikacin resistance in Escherichia coliAntimicrobial Agents and Chemotherapy, 1981